Macrogenics Inc SEC filings MGNX
Macrogenics Inc has 944 filings in SEC EDGAR's recent list, going back to Nov 12, 2003. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jan 10, 2025 | — |
| CORRESP | Letter to the SEC | Jan 3, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2024 | — |
| EFFECT | Filing | Nov 15, 2023 | — |
| CORRESP | Letter to the SEC | Nov 14, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2023 | — |
| EFFECT | Filing | Apr 27, 2023 | — |
| POSASR | Filing | Mar 15, 2023 | — |
| EFFECT | Filing | Jan 3, 2020 | — |
| CORRESP | Letter to the SEC | Dec 31, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2019 | — |
| CORRESP | Letter to the SEC | Dec 11, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2019 | — |
| CT ORDER | Filing | Aug 6, 2019 | — |
| CT ORDER | Filing | Mar 19, 2019 | — |
| CT ORDER | Filing | May 14, 2018 | — |
| CT ORDER | Filing | Mar 12, 2018 | — |
| CT ORDER | Filing | Aug 18, 2017 | — |
| CT ORDER | Filing | Aug 1, 2017 | — |
| CT ORDER | Filing | May 3, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2016 | — |
| CORRESP | Letter to the SEC | Dec 1, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2016 | — |
| CT ORDER | Filing | Sep 1, 2016 | — |
| CT ORDER | Filing | Jun 26, 2015 | — |
| EFFECT | Filing | Nov 21, 2014 | — |
| CT ORDER | Filing | Aug 29, 2014 | — |
| EFFECT | Filing | Feb 12, 2014 | — |
| CT ORDER | Filing | Oct 10, 2013 | — |
| EFFECT | Filing | Oct 9, 2013 | — |
| CERTNAS | Auto-generated paper document | Oct 8, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2013 | — |
| CORRESP | Letter to the SEC | Oct 7, 2013 | — |
| CORRESP | Letter to the SEC | Oct 7, 2013 | — |
| 8-A12B | Form 8-a | Oct 7, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2013 | — |
| CORRESP | Letter to the SEC | Oct 1, 2013 | — |
| CORRESP | Letter to the SEC | Sep 27, 2013 | — |
| CORRESP | Letter to the SEC | Sep 26, 2013 | — |
| CORRESP | Letter to the SEC | Sep 26, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2013 | — |
| DRS | Filing | Aug 2, 2013 | — |
| D | Filing | Jan 31, 2011 | — |
| REGDEX | Auto-generated paper document | Oct 7, 2008 | — |
| REGDEX | Auto-generated paper document | Jul 29, 2008 | — |
| REGDEX | Auto-generated paper document | May 26, 2006 | — |
| REGDEX | Auto-generated paper document | Oct 21, 2004 | — |
| REGDEX | Auto-generated paper document | Nov 12, 2003 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MGNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1125345
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.